Dr. Daniel Alberto Yelfimov, MD

Dr. Yelfimov practices at Urology Partners of North Texas in Arlington, Texas.

Dr. Yelfimov's NPI, 1720309685, was assigned on June 15, 2010. Dr. Yelfimov graduated from Indiana University School Of Medicine in 2010. Dr. Yelfimov holds Texas license Q4550.

Dr. Yelfimov's primary practice is Urology Partners of North Texas, at 5001 S Cooper St, Arlington, TX 76017 in Tarrant County. The practice phone is (866) 367-8768.

Dr. Yelfimov's primary practice is Urology Partners of North Texas in Arlington, Texas. Dr. Yelfimov is also affiliated with Methodist Hospital. The medical group on file is Urology Partners of North Texas. Dmand AI also links Dr. Yelfimov to 2 more hospitals, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yelfimov practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Yelfimov's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Yelfimov is board certified in urology by the American Board of Urology. Dmand AI has Dr. Yelfimov's licenses on file in 3 states: Texas, North Dakota and Minnesota.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery and kidney stone disease among the conditions Dr. Yelfimov treats.

CMS data shows 5,486 Medicare services from Dr. Yelfimov across 33 procedure codes in 2024, for 717 Medicare patients. Medicare paid $207,134 for them.

CMS counts 717 Medicare patients who saw Dr. Yelfimov in 2024. The largest group is 65 to 74, with 323 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Yelfimov's median patient age at 68, with 25% women.

In 2024, Dr. Yelfimov wrote 2,772 Medicare Part D claims for 663 patients. 84% of them were for generic drugs. CMS names the drug for 2,629 of them, across 31 drugs with 11 or more claims each, at $1,579,492 in total drug cost. In 2023, CMS named 2,148 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Yelfimov for performance year 2024, reported as part of a group. Dr. Yelfimov accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yelfimov as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Yelfimov, published from 2012 to 2016. 2012 was the busiest year, with 2. The most frequent topics are Laparoscopy. Dr. Yelfimov has published most often in Urology. Dr. Yelfimov's most frequent co-authors are Stephen Anthony Boorjian, MD, Matthew K. Tollefson, MD and Igor Frank, MD.

CMS Open Payments shows 50 general payments to Dr. Yelfimov from 18 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 93% of the total. Astellas Pharma US Inc paid the most, $334. It also lists 1 research payment totaling $206,884 in 2024.

Dr. Yelfimov graduated from Indiana University School Of Medicine in 2010.

Dr. Yelfimov is in network with 21 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of North Dakota. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.